Compare VYNE & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYNE | COSM |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 18.9M |
| IPO Year | 2017 | 2009 |
| Metric | VYNE | COSM |
|---|---|---|
| Price | $0.60 | $0.38 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 323.6K | ★ 638.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 45.58 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $54,426,402.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.97 |
| 52 Week Low | $0.29 | $0.28 |
| 52 Week High | $2.05 | $1.32 |
| Indicator | VYNE | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 44.61 |
| Support Level | $0.55 | $0.35 |
| Resistance Level | $0.60 | $0.41 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 56.07 | 51.20 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.